Can venetoclax cure leukemia? How long is the survival period?

Venetoclax is a targeted therapy approved to treat AML in adults 75 years of age or older, or in people with other diseases that preclude intensive induction chemotherapy. Venetoclax is taken once daily in combination with azacitidine, decitabine, or low-dose cytarabine. Tablets should be swallowed whole without crushing, chewing, or breaking before swallowing.

Veneclar cannot cure leukemia, but it can delay the progression of the disease and prolong survival. Venaclat +Azacitidine treats AML patients with IDH mutations h1/2)The results for AML patients are encouraging as 75.4% of The patient achieved complete response (CR)/CRi with treatment with venetoclax and azacitidine and prolonged overall survival. Treatment with the combination of venetoclax can achieve a higher complete remission rate (CR)/Incomplete blood cell count recovery rate (CRi) (48%–66%) , prolonged overall survival (OS) (median 7.2–14.7 span> months) and rapid response, with the median time to first response being 1.2–1.4 months. The treatment effect is still optimistic.

Veneclar kills cancer cells by inhibitingBCL-2, a group of proteins that regulate cell death by inhibiting or inducing apoptosis. Apoptosis is an ordered form of cell death in which cellular contents are "packaged" for collection by immune cells. This is different from how cells die due to damage. In certain cancers, such as CLL (chronic lymphocytic leukemia) and AML(Acute myeloid leukemia), CLL and AML have large amounts of BCL-2 on their cell surfaces. This overexpression of BCL-2 allows tumor cells to survive longer and is associated with resistance to chemotherapy. The retail price of generic venetoclax100mg120 tablets ranges from 2 to 6 more than a thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0